The bacterial instrument as a promising therapy for colon cancer
- PMID: 32130489
- DOI: 10.1007/s00384-020-03535-9
The bacterial instrument as a promising therapy for colon cancer
Abstract
Objective: Colon cancer is a great health concern worldwide, as it is the second leading cause of cancer-related death. Conventional treatment of cancer such as surgery, radiotherapy, and chemotherapy are faced with limitations and side effects. Therefore, strategies for the treatment of cancer need to be modified or new strategies replacing the old one.
Aims: The aim of this study is to review the role of bacteria or their products (such as peptides, bacteriocins, and toxins) as a therapeutic agent for colon cancer.
Results and conclusion: Recently, the therapeutic role of bacteria and their products in colon cancer treatment holds promise as emerging novel anti-cancer agents. Unlike the conventional treatments, targeted therapy based on the use of bacteria that are able to directly target tumor cells without affecting normal cells is evolving as an alternative strategy. Moreover, several bacterial species were used in live, attenuated or genetically modified that are able to multiply selectively in tumors and inhibiting their growth.
Keywords: Bacterial peptide; Bacteriocins; Bacteriotherapy; Colon cancer; Toxin.
Similar articles
-
Bacteriotherapy in gastrointestinal cancer.Life Sci. 2020 Aug 1;254:117754. doi: 10.1016/j.lfs.2020.117754. Epub 2020 May 7. Life Sci. 2020. PMID: 32389833 Review.
-
Bacteriotherapy in Breast Cancer.Int J Mol Sci. 2019 Nov 23;20(23):5880. doi: 10.3390/ijms20235880. Int J Mol Sci. 2019. PMID: 31771178 Free PMC article. Review.
-
Bacteria as a double-action sword in cancer.Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188388. doi: 10.1016/j.bbcan.2020.188388. Epub 2020 Jun 23. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32589907 Review.
-
Bacteria and cancer: Different sides of the same coin.Life Sci. 2020 Apr 1;246:117398. doi: 10.1016/j.lfs.2020.117398. Epub 2020 Feb 4. Life Sci. 2020. PMID: 32032647 Review.
-
Bacterial Peptides and Bacteriocins as a Promising Therapy for Solid Tumor.Curr Pharm Des. 2022;28(38):3105-3113. doi: 10.2174/1381612828666220921150037. Curr Pharm Des. 2022. PMID: 36154595 Review.
Cited by
-
Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.BMC Gastroenterol. 2022 Apr 16;22(1):190. doi: 10.1186/s12876-022-02257-2. BMC Gastroenterol. 2022. PMID: 35429970 Free PMC article.
-
Probiotic-derived ferrichrome induces DDIT3-mediated antitumor effects in esophageal cancer cells.Heliyon. 2024 Mar 15;10(6):e28070. doi: 10.1016/j.heliyon.2024.e28070. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38545201 Free PMC article.
-
Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health.Heliyon. 2024 Aug 29;10(17):e37054. doi: 10.1016/j.heliyon.2024.e37054. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286220 Free PMC article. Review.
-
Colon Cancer Disease Diagnosis Based on Convolutional Neural Network and Fishier Mantis Optimizer.Diagnostics (Basel). 2024 Jul 2;14(13):1417. doi: 10.3390/diagnostics14131417. Diagnostics (Basel). 2024. PMID: 39001307 Free PMC article.
-
Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications.Int J Environ Res Public Health. 2022 Sep 19;19(18):11825. doi: 10.3390/ijerph191811825. Int J Environ Res Public Health. 2022. PMID: 36142096 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424 - PubMed
-
- Cao C, Yan TD, Black D, Morris DL (2009) A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 16(8):2152–2165 - DOI
-
- Sugarbaker PH (2016) Improving oncologic outcomes for colorectal cancer at high risk for local–regional recurrence with novel surgical techniques. Expert Rev Gastroenterol Hepatol 10(2):205–213 - DOI
-
- Symeonidis D, Christodoulidis G, Koukoulis G, Spyridakis M, Tepetes K (2011) Colorectal cancer surgery in the elderly: limitations and drawbacks. Tech Coloproctol 15(1):47–50 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources